These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8258464)

  • 41. Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. mangala.rao@na.amedd.army.mil.
    Rao M; Alving CR
    Adv Drug Deliv Rev; 2000 Mar; 41(2):171-88. PubMed ID: 10699313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
    Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
    J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic control of hapten-reactive helper T-cell responses and its implications for the generation of augmented antitumor cytotoxic responses.
    Mizushima Y; Fujiwara H; Takai Y; Shearer GM; Hamaoka T
    J Natl Cancer Inst; 1985 Jun; 74(6):1269-73. PubMed ID: 3158772
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells.
    Mitchell DA; Nair SK; Gilboa E
    Eur J Immunol; 1998 Jun; 28(6):1923-33. PubMed ID: 9645374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antigen delivery with poly(propylacrylic acid) conjugation enhances MHC-1 presentation and T-cell activation.
    Flanary S; Hoffman AS; Stayton PS
    Bioconjug Chem; 2009 Feb; 20(2):241-8. PubMed ID: 19125614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages.
    Tobian AA; Canaday DH; Boom WH; Harding CV
    J Immunol; 2004 May; 172(9):5277-86. PubMed ID: 15100266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteasome inhibitors block the entry of liposome-encapsulated antigens into the classical MHC class I pathway.
    Rothwell SW; Wassef NM; Alving CR; Rao M
    Immunol Lett; 2000 Oct; 74(2):141-52. PubMed ID: 10996390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Defining cytolytic T lymphocyte recognition of chemically modified self. I. Response to trinitrophenyl-H-2Kk.
    Handa K; Herrmann S
    J Immunol; 1985 Sep; 135(3):1564-72. PubMed ID: 2410495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MHC class I+/II- dendritic cells induce hapten-specific immune responses in vitro and in vivo.
    Kolesaric A; Stingl G; Elbe-Bürger A
    J Invest Dermatol; 1997 Oct; 109(4):580-5. PubMed ID: 9326394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway.
    Garg N; Nunes MP; Tarleton RL
    J Immunol; 1997 Apr; 158(7):3293-302. PubMed ID: 9120286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Major histocompatibility complex control of the class of the immune response to the hapten trinitrophenyl.
    Dieli F; Asherson GL; Bonanno CT; Sireci G; Salerno A
    Immunology; 1995 Mar; 84(3):355-9. PubMed ID: 7751016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells.
    Chikh GG; Kong S; Bally MB; Meunier JC; Schutze-Redelmeier MP
    J Immunol; 2001 Dec; 167(11):6462-70. PubMed ID: 11714813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced major histocompatibility complex class I-dependent presentation of antigens modified with cationic and fusogenic peptides.
    Laus R; Graddis TJ; Hakim I; Vidovic D
    Nat Biotechnol; 2000 Dec; 18(12):1269-72. PubMed ID: 11101805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigation of antigen delivery route in vivo and imune-boosting effects mediated by pH-sensitive liposomes encapsulated with K(b)-restricted CTL epitope.
    Lee KY; Chun E; Seong BL
    Biochem Biophys Res Commun; 2002 Apr; 292(3):682-8. PubMed ID: 11922620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.
    Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC
    Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes.
    Wu JY; Gardner BH; Kushner NN; Pozzi LA; Kensil CR; Cloutier PA; Coughlin RT; Newman MJ
    Cell Immunol; 1994 Apr; 154(1):393-406. PubMed ID: 7907530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.
    Kovacsovics-Bankowski M; Clark K; Benacerraf B; Rock KL
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4942-6. PubMed ID: 8506338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Delivery of protein antigen to the major histocompatibility complex class I-restricted antigen presentation pathway.
    Zhou F; Huang L
    J Drug Target; 1995; 3(2):91-109. PubMed ID: 7496732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.